JARID2 and cancer: ALK expression was associated with methylation of regions/probes harboring repressive histone marks as indicated by the enrichment of chromatin regulators of the PRC2 complex (EZH2, SUZ12, and JARID2), which has been described as “epigenetic switching” in cancer 80.